Key takeaways Animal studies show BPC-157 improves gastric motility and protects against gastric damage in rats No human clinical trial has tested BPC-157 for gastroparesis specifically BPC-157 modulates the nitric oxide system and may interact with vagal nerve function, both relevant to gastroparesis Oral administration (250-500 mcg daily) is preferred over injection for GI-targeted effects BPC-157 is unusually stable in stomach acid, making oral delivery viable Patients should work with their gastroenterologist before adding BPC-157 to their gastroparesis management What is gastroparesis and why is it hard to treat
Knowing which kind you're looking at saves you money and frustration
If youre dealing with chronic tendon pain, a slow-healing injury, or youre an athlete looking for the next edge, talk to our qualified Melbourne sports chiropractor who stays up-to-date with the evidence for regenerative and orthobiological medicine
For example, IGFBP-3 has been shown to bind to the type I collagen molecule, thereby playing a role in storing IGFs within the skeletal matrix
Reconstituted BPC-157 typically remains viable for several weeks when stored consistently under refrigeration, though the exact window depends on the specific vial and manufacturer guidance
Podaje si go w postaci cotygodniowego zastrzyku, zgodnie z dawkami ustalonymi przez lekarza
